[go: up one dir, main page]

PA8489901A1 - Derivados de monosacaridos como inhibidores de adhesion celular - Google Patents

Derivados de monosacaridos como inhibidores de adhesion celular

Info

Publication number
PA8489901A1
PA8489901A1 PA20008489901A PA8489901A PA8489901A1 PA 8489901 A1 PA8489901 A1 PA 8489901A1 PA 20008489901 A PA20008489901 A PA 20008489901A PA 8489901 A PA8489901 A PA 8489901A PA 8489901 A1 PA8489901 A1 PA 8489901A1
Authority
PA
Panama
Prior art keywords
cell adhesion
derivatives
compounds
adhesion inhibitors
isopropilideno
Prior art date
Application number
PA20008489901A
Other languages
English (en)
Spanish (es)
Inventor
Sudershan K Arora
Jang B Gupta
Nawal Kishore
Vishwas D Joshi
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of PA8489901A1 publication Critical patent/PA8489901A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Surgery (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
PA20008489901A 1999-01-15 2000-01-14 Derivados de monosacaridos como inhibidores de adhesion celular PA8489901A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN86DE1999 IN190975B (pt) 1999-01-15 1999-01-15
US09/276,368 US6590085B1 (en) 1999-01-15 1999-03-25 Derivatives of monosaccharides as cell adhesion inhibitors

Publications (1)

Publication Number Publication Date
PA8489901A1 true PA8489901A1 (es) 2000-09-29

Family

ID=11088155

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20008489901A PA8489901A1 (es) 1999-01-15 2000-01-14 Derivados de monosacaridos como inhibidores de adhesion celular

Country Status (31)

Country Link
US (5) US6590085B1 (pt)
EP (1) EP1147119B1 (pt)
JP (1) JP2002534530A (pt)
CN (1) CN1167707C (pt)
AR (1) AR022235A1 (pt)
AT (1) ATE250074T1 (pt)
AU (1) AU768511B2 (pt)
BG (1) BG105745A (pt)
BR (1) BR0007553A (pt)
CA (1) CA2359986A1 (pt)
CO (1) CO5180591A1 (pt)
CR (1) CR6423A (pt)
CZ (1) CZ20012540A3 (pt)
DE (1) DE60005300T2 (pt)
DK (1) DK1147119T3 (pt)
ES (1) ES2206176T3 (pt)
HK (1) HK1041270A1 (pt)
HR (1) HRP20010529B1 (pt)
HU (1) HUP0105116A3 (pt)
ID (1) ID30351A (pt)
IN (1) IN190975B (pt)
MA (1) MA25342A1 (pt)
MX (1) MXPA01007187A (pt)
MY (1) MY121135A (pt)
NZ (2) NZ512852A (pt)
PA (1) PA8489901A1 (pt)
PT (1) PT1147119E (pt)
SK (1) SK284241B6 (pt)
TR (1) TR200102043T2 (pt)
WO (1) WO2000042054A1 (pt)
YU (1) YU50701A (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN190975B (pt) * 1999-01-15 2003-09-06 Ranbaxy Lab Ltd
AU2004242777B2 (en) 2003-05-30 2011-05-12 Ranbaxy Laboratories Limited Substituted pyrrole derivatives and their use as HMG-Co inhibitors
EP1789428A1 (en) * 2004-09-02 2007-05-30 Ranbaxy Laboratories Limited Monosaccharide derivatives
EP1902063A2 (en) * 2004-12-22 2008-03-26 Ranbaxy Laboratories Limited Derivatives of pentose monosaccharides as anti-inflammatory compounds
WO2007010499A2 (en) * 2005-07-22 2007-01-25 Ranbaxy Laboratories Limited Derivatives of monosaccharides for the treatment of copd and allergic rhinitis
KR101329112B1 (ko) * 2005-11-08 2013-11-14 랜박시 래보러터리스 리미티드 (3ｒ,5ｒ)-7-〔2-(4-플루오로페닐)-5-이소프로필-3-페닐-4-〔(4-히드록시 메틸 페닐 아미노)카르보닐〕-피롤-1-일〕-3,5-디히드록시 헵탄산 헤미 칼슘염의 제조 방법
CL2007000667A1 (es) * 2006-03-14 2008-03-14 Ranbaxi Lab Ltd Composicion farmaceutica que comprende al acido 7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroximetilfenilamino)carbonil]pirrol-1-il]-3,5-dihidroxi-heptanoico o una sal y al menos un agente estabilizante; procedimiento de preparacion, util en e
US20080114031A1 (en) * 2006-03-29 2008-05-15 Sattigeri Viswajanani J Monosaccharide derivatives
EP1864992A2 (en) * 2006-05-30 2007-12-12 Ranbaxy Laboratories, Ltd. Monosaccharide derivatives
US20080300196A1 (en) * 2006-10-03 2008-12-04 Ashwani Kumar Verma Monosaccharide derivatives
AU2008221506B2 (en) * 2007-09-20 2011-01-20 ResMed Pty Ltd Retractable Tube for CPAP

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2715121A (en) 1950-09-09 1955-08-09 American Home Prod Alkyl sugar derivatives and their preparation
US4056322A (en) 1973-12-14 1977-11-01 Strategic Medical Research Corporation Preparation of ethers of monosaccharides
US4735934A (en) 1981-02-17 1988-04-05 Greenwich Pharmaceuticals Incorporated Method of therapeutically treating a warm blooded animal afflicted with an autoimmune disease
US4996195A (en) * 1989-01-09 1991-02-26 Greenwich Pharmaceuticals Inc. Derivatives of α,D-glucofuranose or α,D-allofuranose and intermediates for preparing these derivatives
US5010058A (en) 1989-06-22 1991-04-23 501 Greenwich Pharmaceuticals Incorporated 3,5,6-substituted derivatives of 1,2-O-isopropylidene-α,D-glucofuranose and intermediates for preparing these derivatives
FR2652540B1 (fr) 1989-10-02 1995-06-02 Imaje Sa Circuit d'encre notamment destine a la mise en pression d'une encre a pigments pour imprimante a jet d'encre.
US5192746A (en) 1990-07-09 1993-03-09 Tanabe Seiyaku Co., Ltd. Cyclic cell adhesion modulation compounds
US5258402A (en) 1992-06-11 1993-11-02 Mcneil-Ppc, Inc. Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates
US5432163A (en) 1992-11-13 1995-07-11 Greenwich Pharmaceuticals Incorporated Anti-proliferative and anti-inflammatory compounds: derivatives of pentose monosaccharides
US5637570A (en) * 1995-05-09 1997-06-10 Chemora Pharmochem Disubstituted and trisubstituted derivatives of 2,3:4,6-di-O-isopropylidene-α-L-xylo-2-hexulofuranosonic acid having anti-cancer, anti-inflammatory and anti-proliferative activity
IN190975B (pt) * 1999-01-15 2003-09-06 Ranbaxy Lab Ltd

Also Published As

Publication number Publication date
ATE250074T1 (de) 2003-10-15
WO2000042054A1 (en) 2000-07-20
CZ20012540A3 (cs) 2002-02-13
CA2359986A1 (en) 2000-07-20
HK1041270A1 (en) 2002-07-05
HUP0105116A3 (en) 2003-05-28
US20040029820A1 (en) 2004-02-12
US20040019191A1 (en) 2004-01-29
US7005422B2 (en) 2006-02-28
SK284241B6 (en) 2004-11-03
MY121135A (en) 2005-12-30
HRP20010529A2 (en) 2002-08-31
CR6423A (pt) 2004-03-09
NZ527483A (en) 2005-02-25
MA25342A1 (fr) 2001-12-31
US7005516B2 (en) 2006-02-28
AU768511B2 (en) 2003-12-18
EP1147119A1 (en) 2001-10-24
JP2002534530A (ja) 2002-10-15
YU50701A (sh) 2005-06-10
SK10132001A3 (sk) 2002-01-07
US20040023900A1 (en) 2004-02-05
ES2206176T3 (es) 2004-05-16
BR0007553A (pt) 2001-12-18
DK1147119T3 (da) 2004-01-19
HUP0105116A2 (hu) 2003-04-28
NZ512852A (en) 2004-02-27
AU1886100A (en) 2000-08-01
HRP20010529B1 (en) 2005-02-28
US7037899B2 (en) 2006-05-02
CN1167707C (zh) 2004-09-22
TR200102043T2 (tr) 2001-11-21
IN190975B (pt) 2003-09-06
US20040018995A1 (en) 2004-01-29
CO5180591A1 (es) 2002-07-30
ID30351A (id) 2001-11-22
DE60005300D1 (de) 2003-10-23
PT1147119E (pt) 2004-02-27
CN1343213A (zh) 2002-04-03
MXPA01007187A (es) 2002-04-24
EP1147119B1 (en) 2003-09-17
BG105745A (en) 2002-05-31
AR022235A1 (es) 2002-09-04
DE60005300T2 (de) 2004-07-15
US6590085B1 (en) 2003-07-08

Similar Documents

Publication Publication Date Title
PA8489901A1 (es) Derivados de monosacaridos como inhibidores de adhesion celular
ES2183937T3 (es) Inhibidores de la adhesion celular.
EA199800119A1 (ru) Ингибиторы адгезии клеток
BRPI1014956B8 (pt) agentes anti-inflamatórios
MX2019007708A (es) Nuevos agentes anti-inflamatorios.
MXPA04012691A (es) Derivados de azabiciclo-octano y nonano con actividad inhibitoria de dpp-iv.
BR0208667A (pt) Antagonistas da função de mcp-1 e métodos de uso dos mesmos
ECSP055856A (es) Derivados de 3-aminopirrolidina como moduladores de receptores de quimocina
BR0009869A (pt) Método para inibir a produção e/ou secreção de citoquina, e, composição farmacêutica
DE69301995D1 (de) Verfahren zur Herstellung von Elektroden für saure Bleibatterien
AR011168A1 (es) Compuestos derivados del acido hexanoico, composiciones que los contiene, y procedimiento de tratamiento
ATE318841T1 (de) Biarylalkansäuren in der verwendung als zelladhäsionsinhibitoren
CL2004000255A1 (es) Compuestos derivados del pirrol sustituidos con heterociclos, composicion farmaceutica, utiles para tratar osteoartritis, aneurisma, fiebre, enfermedades autoinmunes, psoriasis, asma, entre otras.
BR9713993A (pt) Pirazóis como inibidores de fosfolipase a2 secretora não pancreática humana
MX2010007024A (es) Tioéteres c-21 como agonista del receptor de glucocorticoides.
MX161889A (es) Procedimiento para tenir el acido desoxiribonucleico de celulas vivientes de mamiferos
IL152961A0 (en) Inhibitors of alpha beta 2 mediated cell adhesion
ES8406448A1 (es) Procedimiento para la preparacion de fenilsulfoniloxibencimidazolcarbamatos sustituidos
AR023546A1 (es) Disulfuros ciclicos de pirrolidincarbonilamina
ES8604223A1 (es) Un procedimiento para preparar derivados de purina
ES8203824A1 (es) Procedimiento para preparar esteres de 2-nitro-5-fenoxi sustituido)benzoato de alfa-hidroxialcanoatos
BR9810705A (pt) Processo para a produção de metacrilato de metila
ECSP972275A (es) Derivados de acidos hidroxamico
ATE29713T1 (de) Arphamenin und ihm verwandte verbindungen, ein verfahren zu ihrer herstellung und ihre verwendung als medikamente.
AR223017A1 (es) Nuevo procedimiento para la produccion del ester del guayacol del acido acetilsalicilico